Nisa Investment Advisors LLC boosted its holdings in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 8.7% during the 4th quarter, HoldingsChannel.com reports. The fund owned 3,719 shares of the company’s stock after buying an additional 299 shares during the period. Nisa Investment Advisors LLC’s holdings in HealthEquity were worth $357,000 as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of the business. UMB Bank n.a. lifted its holdings in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after purchasing an additional 164 shares in the last quarter. Paladin Wealth LLC bought a new stake in shares of HealthEquity during the 3rd quarter worth approximately $39,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in HealthEquity during the 2nd quarter valued at $73,000. GAMMA Investing LLC increased its holdings in HealthEquity by 57.8% during the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock worth $77,000 after purchasing an additional 344 shares during the period. Finally, Quarry LP boosted its stake in shares of HealthEquity by 418.8% during the third quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after purchasing an additional 1,089 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.
HealthEquity Price Performance
HQY opened at $108.80 on Thursday. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a market cap of $9.43 billion, a price-to-earnings ratio of 99.82, a PEG ratio of 1.86 and a beta of 0.54. The stock’s 50-day moving average price is $99.85 and its 200 day moving average price is $88.02. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $111.36.
Insider Activity at HealthEquity
In other news, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $101.56, for a total value of $837,870.00. Following the sale, the director now directly owns 66,469 shares in the company, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 34,289 shares of company stock worth $3,355,718. Company insiders own 2.20% of the company’s stock.
Analysts Set New Price Targets
Several brokerages have recently issued reports on HQY. Barrington Research raised their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. Bank of America upped their price target on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, November 13th. The Goldman Sachs Group started coverage on HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 target price on the stock. BTIG Research raised their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. Finally, Mizuho started coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $110.71.
Check Out Our Latest Stock Analysis on HealthEquity
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Stories
- Five stocks we like better than HealthEquity
- What is the Shanghai Stock Exchange Composite Index?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 3 Steel Stocks Soaring After Tariff Announcements
- What is a Dividend King?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.